It does cause weight loss as a side effect, but not at the level of semaglutide or tirzepatide
The medication also produced a mean 9.4% weight loss and improvements in blood pressure (3.3 mm Hg systolic), inflammatory markers (37.8% high-sensitivity CRP), and lipid profilesall achieved on top of existing treatments
"If you want to drink it, you really need to dilute it with water or put some in your tea to minimize damage to the esophagus or tooth enamel," she said
How the Oral Wegovy Launch Highlights Broader Market Access Challenges The January 5, 2026 availability of oral Wegovy represents more than just a format option-it highlights the ongoing tension between pharmaceutical innovation and consumer affordability that characterizes the GLP-1 weight loss market
Diabetics should closely monitor their blood sugar before, during, and after drinking alcohol
nyc.gov